ACMG releases new Points to Consider statement on the clinical utility of polygenic risk scores for embryo selection
Should we be using polygenic risk score assessment for embryo selection? Providing in-depth analysis, the Social, Ethical and Legal Issues Committee of the American College of Medical Genetics and Genomics (ACMG) has released a new Points to Consider statement to assist healthcare professionals and patients in understanding the safety and utility of preimplantation genetic testing for polygenic disorders (PGT-P) as a clinical service.
Susan Klugman Theresaa Grebe American College Of Medical Genetics Medical Genetics Legal Issues Committee American College
Source: news-medical.net